Visit the Cancer Prevention Journals Portal for the latest prevention articles from AACR's six journals.
|
The world’s most comprehensive transdisciplinary cancer prevention meeting
This popular Frontiers in Cancer Prevention Research Conference promotes public, academic, government, and industry awareness of the vital importance of cancer prevention science in reducing cancer incidence and mortality. It catalyzes coordinated, focused research in basic, clinical, epidemiologic, and behavioral science that promises to accelerate cancer prevention. The exciting ideas presented at this conference benefit the work of investigators in every prevention subspecialty and at every level of career development.
Lead Supporter

|
Supported by a generous educational grant from the National Cancer Institute, NIH, HHS
SCIENTIFIC PROGRAM COMMITTEE CHAIRPERSON:
Ernest T. Hawk, UT M. D. Anderson Cancer Center, Houston, TX
SCIENTIFIC PROGRAM COMMITTEE:
Ding-Shinn Chen, National Taiwan University Hospital, Taipei, Taiwan
Wendy Demark-Wahnefried, UT M. D. Anderson Cancer Center, Houston, TX
Leslie G. Ford, National Cancer Institute, Bethesda, MD
William M. Grady, Fred Hutchinson Cancer Research Center, Seattle, WA
Steven I. Gutman, University of Central Florida, Orlando, FL
Chanita Hughes Halbert, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA
Randy L. Jirtle, Duke University Medical Center, Durham, NC
J. Jack Lee, UT M. D. Anderson Cancer Center, Houston, TX
Kevin Lewis, Colon Cancer Alliance, Washington, DC
Paul J. Limburg, Mayo Clinic College of Medicine, Rochester, MN
Stephen J. Meltzer, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD
William G. Nelson, V, Johns Hopkins University, Baltimore, MD
Roberta B. Ness, University of Texas School of Public Health, Houston, TX
Frank G. Ondrey, University of Minnesota, Minneapolis, MN
Elizabeth A. Platz, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD
Anil K. Rustgi, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA
Peter G. Shields, Lombardi Comprehensive Cancer Center at Georgetown University, Washington, DC
Avrum E. Spira, Boston University Medical Center, Boston, MA
Thea D. Tlsty, University of California School of Medicine, San Francisco, CA
Jaye L. Viner, MedImmune, Inc., Gaithersburg, MD
Thomas D. Wang, University of Michigan, Ann Arbor, MI
David W. Wetter, UT M. D. Anderson Cancer Center, Houston, TX
David C. Whiteman, Queensland Institute of Medical Research, Herston, QLD, Australia